Elimination of Soybean Lipid Emulsion in Parenteral Nutrition and Supplementation With Enteral Fish Oil Improve Cholestasis in Infants With Short Bowel Syndrome

Abstract

Background

Parenteral nutrition–associated liver disease (PNALD) is a potentially fatal complication for children with intestinal failure. Fish oil–based lipid emulsions have shown promise for the treatment of PNALD but are not readily available. Six cases are presented in which cholestasis resolved after soybean lipid emulsion (SLE) was removed from parenteral nutrition (PN) and enteral fish oil was given.

Methods

A retrospective review at a tertiary children’s hospital (July 2003 to August 2008) identified 6 infants with intestinal failure requiring PN for >6 months who developed severe hepatic dysfunction that was managed by eliminating SLE and providing enteral fish oil.

Results

Twenty-three infants with short bowel syndrome requiring prolonged PN developed cholestasis. SLE was removed in 6 of these patients, and 4 of the 6 received enteral fish oil. Standard PN included 2-3 g/kg/d SLE with total PN calories ranging from 57 to 81 kcal/kg/d at the time of SLE removal. Hyperbilirubinemia resolved after elimination of SLE within 1.8-5.4 months. Total PN calories required to maintain growth generally did not change.

Conclusions

Temporary elimination of SLE and supplementation with enteral fish oil improved cholestasis in PN-dependent infants. Further trials are needed to evaluate this management strategy.

Keywords

short bowel syndrome cholestasis liver diseases parenteral nutrition soybean oil fish oils liver failure hyperbilirubinemia

Get full access to this article

View all access options for this article.

References

Kelly

. Intestinal failure-associated liver disease: what do we know today? Gastroenterology. 2006;130(2 suppl 1):S70-S77.

Marik

. Maximizing efficacy from parenteral nutrition in critical care: appropriate patient populations, supplemental parenteral nutrition, glucose control, parenteral glutamine, and alternative fat sources. Curr Gastroenterol Rep. 2007;9:345-353.

Cavicchi

Beau

Crenn

Degott

Messing

. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525-532.

Clayton

Whitfield

Iyer

. The role of phytosterols in the pathogenesis of live complications of pediatric parenteral nutrition. Nutrition. 1998;14:158-164.

Colomb

Goulet

De Potter

Ricour

. Liver disease associated with long-term parenteral nutrition in children. Transplant Proc. 1994;26:1467.

Diamond

Sterescu

Pencharz

Wales

. The rationale for the use of parenteral omega-3 lipids in children with short bowel syndrome and liver disease. Pediatr Surg Int. 2008;24:773-778.

Guglielmi

Regano

Mazzuoli

. Cholestasis induced by total parenteral nutrition. Clin Liver Dis. 2008;12:97-110, viii.

Colomb

Jobert-Giraud

Lacaille

Goulet

Fournet

Ricour

. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000;24:345-350.

Gura

Lee

Valim

. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008;121:e678-e686.

10.

Sondheimer

Asturias

Cadnapaphornchai

. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 1998;27:131-137.

11.

Gura

Parsons

Bechard

. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr. 2005;24:839-847.

12.

American Academy of Pediatrics, Committee on Nutrition. Use of intravenous fat emulsions in pediatric patients. Pediatrics. 1981;68:738-743.

13.

Heller

Rossler

Litz

. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34:972-979.

14.

Ekema

Falchetti

Boroni

. Reversal of severe parenteral nutrition-associated liver disease in an infant with short bowel syndrome using parenteral fish oil (omega-3 fatty acids). J Pediatr Surg. 2008;43:1191-1195.

15.

Gura

Duggan

Collier

. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006;118:e197-e201.

16.

Nishimura

Yamaguchi

Naito

Yamauchi

. Soybean oil fat emulsion to prevent TPN-induced liver damage: possible molecular mechanisms and clinical implications. Biol Pharm Bull. 2006;29:855-862.

17.

Oshita

Takehara

Yamaguchi

. Significance of administration of fat emulsion: hepatic changes in infant rats receiving total parenteral nutrition with and without fat. Clin Nutr. 2004;23:1060-1068.

18.

Innis

. Omega-3 Fatty acids and neural development to 2 years of age: do we know enough for dietary recommendations? J Pediatr Gastroenterol Nutr. 2009;48(suppl 1):S16-S24.